{"date":"2026-03-12","count":119,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2026-03-12-2332-1mk09aj","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"23:32:55","subject":"歐盟核發本公司Bonvadis外用醫材用於急性、慢性傷口及疤痕等適應症之上市許可(品質管理系統證書)，准許於歐盟27國上市，達成全球上市重要里程碑。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-12 23:32，「歐盟核發本公司Bonvadis外用醫材用於急性、慢性傷口及疤痕等適應症之上市許可(品質管理系統證書)，准許於歐盟27國上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-12-2210-1vypvg3","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"22:10:51","subject":"(更正連結)本公司受邀參加摩根士丹利舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-12 22:10，「(更正連結)本公司受邀參加摩根士丹利舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-12-2143-11wjw0o","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"21:43:44","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-12 21:43，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-12-2143-15pqx47","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"21:43:24","subject":"公告本公司董事會決議通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-12 21:43，「公告本公司董事會決議通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-12-2143-1howjn","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"21:43:00","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-12 21:43，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-2049-ofgaj3","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"20:49:43","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告","clause":"第23款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 20:49，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-2049-1xfnf2g","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"20:49:28","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定公告","clause":"第23款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 20:49，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-03-12-2020-14gs42k","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"20:20:51","subject":"公告本公司董事會決議115年股東常會相關事宜(新增議案)","clause":"第32款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-03-12 20:20，「公告本公司董事會決議115年股東常會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-03-12-2013-bwopfv","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"20:13:56","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-03-12 20:13，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-2012-98tuyd","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"20:12:33","subject":"本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 20:12，「本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-03-12-2007-7j886t","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"20:07:11","subject":"公告本公司董事會通過民國114年度個別財務報告","clause":"第43款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-03-12 20:07，「公告本公司董事會通過民國114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1925-5xjbf0","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:25:33","subject":"公告本公司董事會決議召開115年股東會相關事宜","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:25，「公告本公司董事會決議召開115年股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1925-gdilr7","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:25:14","subject":"(補充說明114年12月11日)代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本公司董事會授權董事長簽訂股權轉讓意向書","clause":"第10款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:25，「(補充說明114年12月11日)代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1924-152642x","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:24:27","subject":"代子公司依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告","clause":"第22款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:24，「代子公司依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1923-1pi1gre","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:23:42","subject":"依公開發行公司資金貸與及背書保證處理準則 第22條第1項第3款公告","clause":"第23款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:23，「依公開發行公司資金貸與及背書保證處理準則 第22條第1項第3款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1922-bwopfv","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:22:51","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:22，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-12-1922-1sxywti","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:22:36","subject":"公告本公司董事會通過114年度合併財務報告案","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-12 19:22，「公告本公司董事會通過114年度合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1915-1iwh1ot","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:15:47","subject":"公告本公司董事會決議召開115年股東常會事宜(增列召集事宜)","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 19:15，「公告本公司董事會決議召開115年股東常會事宜(增列召集事宜)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-12-1913-1udfxa9","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"19:13:07","subject":"董事會決議召開115年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-12 19:13，「董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-03-12-1904-11wjw0o","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:04:29","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-03-12 19:04，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1900-1sope0d","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"19:00:49","subject":"本公司經櫃買中心同意，自115年03月13日起恢復交易","clause":"第40款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 19:00，「本公司經櫃買中心同意，自115年03月13日起恢復交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-03-12-1856-17snutz","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:56:45","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-03-12 18:56，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-12-1856-1f1swft","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:56:23","subject":"公告本公司取得會計師114年度內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-12 18:56，「公告本公司取得會計師114年度內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-03-12-1852-isqttc","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:52:42","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-03-12 18:52，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-03-12-1850-5j9yh6","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:50:05","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-03-12 18:50，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-12-1847-17q7vhg","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:47:31","subject":"代子公司嘉文麗(福建)化妝品有限公司公告向關係人取得不動產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-12 18:47，「代子公司嘉文麗(福建)化妝品有限公司公告向關係人取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-12-1846-92x690","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:46:04","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-12 18:46，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1845-1wmmw7h","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:45:03","subject":"公告本公司董事會決議通過一一五年股東常會新增召集事由","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:45，「公告本公司董事會決議通過一一五年股東常會新增召集事由」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-12-1844-1hds7fq","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:44:49","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-12 18:44，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-12-1843-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:43:55","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-12 18:43，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-03-12-1843-11c25t2","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:43:31","subject":"公告本公司董事會決議114年度盈餘分派案","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-03-12 18:43，「公告本公司董事會決議114年度盈餘分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1832-1p325vl","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:32:52","subject":"本公司董事會決議通過一一四年下半年度盈餘分派股利事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:32，「本公司董事會決議通過一一四年下半年度盈餘分派股利事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-1830-fqsc9p","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:30:39","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 18:30，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-03-12-1827-1b89la1","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:27:28","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-03-12 18:27，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1824-1l07qae","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:24:22","subject":"公告本公司配合會計師事務所內部輪調機制，調整簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:24，「公告本公司配合會計師事務所內部輪調機制，調整簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-03-12-1824-1v5vvnk","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:24:15","subject":"公告本公司董事會決議通過114年度員工酬勞及董事酬勞分派案","clause":"第44款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-03-12 18:24，「公告本公司董事會決議通過114年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-12-1823-11wjw0o","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:23:59","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-12 18:23，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-03-12-1823-1a0d4zp","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"18:23:31","subject":"代重要子公司From-eyes Co., Ltd.公告盈餘分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-03-12 18:23，「代重要子公司From-eyes Co., Ltd.公告盈餘分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1820-yc1tdx","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:20:55","subject":"公告本公司董事會決議通過盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:20，「公告本公司董事會決議通過盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-12-1820-1p8qsud","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:20:11","subject":"公告本公司董事會通過召集115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-12 18:20，「公告本公司董事會通過召集115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1820-6r8ylr","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:20:10","subject":"公告本公司董事會決議通過辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:20，「公告本公司董事會決議通過辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1819-1glwusd","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:19:47","subject":"公告本公司董事會決議通過轉投資之境外子公司未分配盈餘暫不匯回","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:19，「公告本公司董事會決議通過轉投資之境外子公司未分配盈餘暫不匯回」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-12-1818-5j9yh6","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:18:23","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-12 18:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-12-1817-1egfkms","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:17:51","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-12 18:17，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1816-uqttu8","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:16:34","subject":"公告本公司董事會決議通過一一四年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:16，「公告本公司董事會決議通過一一四年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1816-1j9cmsk","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:16:05","subject":"公告本公司董事會決議通過一一四年度員工酬勞及董事酬勞分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:16，「公告本公司董事會決議通過一一四年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-12-1815-isqttc","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"18:15:13","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-12 18:15，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1806-11qxl45","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:06:28","subject":"公告本公司召開重大訊息說明記者會內容","clause":"第53款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 18:06，「公告本公司召開重大訊息說明記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-03-12-1800-17snutz","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"18:00:52","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-03-12 18:00，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-1759-j7w6qi","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:59:31","subject":"代子公司佐登妮絲國際股份有限公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 17:59，「代子公司佐登妮絲國際股份有限公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-1757-13bqai2","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:57:55","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 17:57，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1754-kiikoo","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:54:49","subject":"公告本公司董事會決議通過股份轉換案","clause":"第11款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 17:54，「公告本公司董事會決議通過股份轉換案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-03-12-1751-92x690","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:51:52","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-03-12 17:51，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-03-12-1751-5j9yh6","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:51:37","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-03-12 17:51，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-12-1746-yclg0e","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:46:04","subject":"公告本公司因會計師事務所內部輪調更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-12 17:46，「公告本公司因會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-03-12-1744-1xd5rpu","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:44:07","subject":"公告本公司董事會通過民國114年合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-03-12 17:44，「公告本公司董事會通過民國114年合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1743-2iz4hx","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:43:07","subject":"公告本公司董事會決議不發放股利","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 17:43，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-12-1743-11b1948","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:43:01","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-12 17:43，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1742-10lmqr3","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:42:39","subject":"公告本公司董事會決議得視金融市場狀況辦理私募有價證券","clause":"第11款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 17:42，「公告本公司董事會決議得視金融市場狀況辦理私募有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1742-h6xgxb","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:42:06","subject":"公告本公司董事會決議114年股東常會通過之私募普通股案，尚餘額度之發行期限將屆滿，屆期則不予辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 17:42，「公告本公司董事會決議114年股東常會通過之私募普通股案，尚餘額度之發行期限將屆滿，屆期則不予辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1741-gfep1d","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:41:29","subject":"公告本公司董事會通過114年第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 17:41，「公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-12-1738-tp7mie","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:38:36","subject":"公告本公司新任創新長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-12 17:38，「公告本公司新任創新長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-12-1737-p67uuk","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:37:26","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-12 17:37，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-12-1737-w50wei","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:37:03","subject":"公告召開本公司115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-12 17:37，「公告召開本公司115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-12-1736-5e664a","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:36:37","subject":"本公司董事會決議分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-12 17:36，「本公司董事會決議分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-12-1733-lzdtk3","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:33:47","subject":"公告本公司董事會決議召開115年股東常會日期及相關事宜(變更開會日期）","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-12 17:33，「公告本公司董事會決議召開115年股東常會日期及相關事宜(變更開會日期）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-12-1717-vsycfd","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:17:18","subject":"公告本公司115年2月份自結合併損益","clause":"第53款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-12 17:17，「公告本公司115年2月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-12-1714-my7iml","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:14:33","subject":"本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-12 17:14，「本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-12-1713-153l23p","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:13:51","subject":"本公司董事會決議通過民國114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-12 17:13，「本公司董事會決議通過民國114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-12-1713-1rgvkdp","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"17:13:15","subject":"本公司董事會決議召開115年股東常會各項事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-12 17:13，「本公司董事會決議召開115年股東常會各項事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1712-bwopfv","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"17:12:50","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 17:12，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-12-1710-bwopfv","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:10:28","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-12 17:10，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-03-12-1706-11b1948","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:06:32","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-03-12 17:06，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-03-12-1704-1dq5wzo","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:04:18","subject":"公告本公司經董事會決議114年度股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-03-12 17:04，「公告本公司經董事會決議114年度股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-03-12-1700-1b89la1","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"17:00:54","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-03-12 17:00，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-03-12-1659-1b89la1","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"16:59:55","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-03-12 16:59，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-03-12-1659-1i127x4","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"16:59:17","subject":"公告本公司董事會通過114年度員工及董事酬勞分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-03-12 16:59，「公告本公司董事會通過114年度員工及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-03-12-1657-d745z1","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"16:57:53","subject":"公告更正112年第二季、112年度、113年第二季、113年度、114年第二季、114年第三季等各期財報部分資訊暨附註揭露事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-03-12 16:57，「公告更正112年第二季、112年度、113年第二季、113年度、114年第二季、114年第三季等各期財報部分資訊暨附註揭」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1653-11b1948","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"16:53:50","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 16:53，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-03-12-1647-5sggiz","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"16:47:31","subject":"本公司受邀參加第一金證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-03-12 16:47，「本公司受邀參加第一金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-12-1646-ihxgmq","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"16:46:23","subject":"本公司董事會決議股利分派 (更正)","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-12 16:46，「本公司董事會決議股利分派 (更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-03-12-1637-61p8d8","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"16:37:55","subject":"本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-03-12 16:37，「本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-03-12-1637-5rax5d","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"16:37:22","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-03-12 16:37，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-03-12-1636-11b1948","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"16:36:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-03-12 16:36，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-03-12-1620-11wjw0o","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"16:20:15","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-03-12 16:20，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-12-1613-5e664a","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"16:13:04","subject":"本公司董事會決議分派股利","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-12 16:13，「本公司董事會決議分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-03-12-1606-kfko1e","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"16:06:43","subject":"公告本公司現金股利除息基準日、發放日","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-03-12 16:06，「公告本公司現金股利除息基準日、發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-12-1557-fqsc9p","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:57:41","subject":"本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-12 15:57，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-03-12-1557-11udt1a","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:57:19","subject":"本公司董事會通過114年度第四季合併財務報告","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-03-12 15:57，「本公司董事會通過114年度第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-12-1555-1howjn","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:55:40","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-12 15:55，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-03-12-1549-10qn6yl","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:49:59","subject":"公告本公司更換股務代理機構案經集保公司准予備查","clause":"第44款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-03-12 15:49，「公告本公司更換股務代理機構案經集保公司准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-12-1538-13f15s5","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:38:31","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-12 15:38，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-03-12-1538-1q7ty1w","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"15:38:12","subject":"代子公司聲博科技股份有限公司公告董事會決議不分派114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-03-12 15:38，「代子公司聲博科技股份有限公司公告董事會決議不分派114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-12-1538-8zdcl8","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:38:11","subject":"本公司董事會決議分派114年度盈餘","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-12 15:38，「本公司董事會決議分派114年度盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-03-12-1538-1dd9qx8","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"15:38:10","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-03-12 15:38，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-12-1537-5j9yh6","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:37:49","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-12 15:37，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-12-1537-1howjn","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:37:23","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-12 15:37，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1530-14sezjt","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:30:56","subject":"公告本公司代理發言人、財務主管、會計主管及公司治理主管異動案","clause":"第11款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 15:30，「公告本公司代理發言人、財務主管、會計主管及公司治理主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1527-1sz8qee","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:27:59","subject":"公告本公司董事會通過總經理晉升案","clause":"第6款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 15:27，「公告本公司董事會通過總經理晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1525-1hufvng","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:25:11","subject":"公告本公司董事會決議以私募方式發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 15:25，「公告本公司董事會決議以私募方式發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-12-1522-ah8nhn","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:22:32","subject":"公告本公司脂肪肝炎新藥SNP-610取得澳洲專利","clause":"第44款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-12 15:22，「公告本公司脂肪肝炎新藥SNP-610取得澳洲專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-12-1522-yhf2i0","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:22:06","subject":"本公司為子公司提供資金貸與,依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款申報事項","clause":"第23款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-12 15:22，「本公司為子公司提供資金貸與,依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款申報事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-12-1521-92x690","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:21:34","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-12 15:21，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-03-12-1521-1406jt2","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"15:21:32","subject":"公告本公司受邀參加台新證券舉辦之法⼈說明會","clause":"第12款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-03-12 15:21，「公告本公司受邀參加台新證券舉辦之法⼈說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1520-1xl66gd","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:20:25","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 15:20，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-03-12-1518-854nkg","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:18:59","subject":"公告本公司董事會決議不繼續辦理114年度股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-03-12 15:18，「公告本公司董事會決議不繼續辦理114年度股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-12-1513-bwopfv","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:13:23","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-12 15:13，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-03-12-1511-1qb15ta","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-12","time":"15:11:24","subject":"公告本公司取得經濟部產業發展署出具之「係屬科技事業及產品開發成功且具市場性」之意見書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-03-12 15:11，「公告本公司取得經濟部產業發展署出具之「係屬科技事業及產品開發成功且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-03-12-1506-5j9yh6","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:06:54","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-03-12 15:06，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-12-1500-11r8ft9","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"15:00:20","subject":"本公司董事會決議召開民國115年股東常會","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-12 15:00，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-12-1453-5j9yh6","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:53:27","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-12 14:53，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-03-12-1430-1e6mw7s","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:30:14","subject":"配合114年度會計師調整數，更正本公司114年12月單月及累計合併營收公告數","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-03-12 14:30，「配合114年度會計師調整數，更正本公司114年12月單月及累計合併營收公告數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-03-12-1428-1fck1r9","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:28:47","subject":"公告本公司董事會通過114年度合併財報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-03-12 14:28，「公告本公司董事會通過114年度合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-03-12-1423-1ctgck9","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:23:44","subject":"本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-03-12 14:23，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-03-12-1423-1udfxa9","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:23:24","subject":"董事會決議召開115年股東常會公告","clause":"第17款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-03-12 14:23，「董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-03-12-1423-5j9yh6","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:23:07","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-03-12 14:23，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-12-1418-xtm68d","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-12","time":"14:18:08","subject":"公告本公司於115年3月12日召開投資人可參與之重大訊息記者會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-12 14:18，「公告本公司於115年3月12日召開投資人可參與之重大訊息記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-12-1115-10e1y9q","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"11:15:18","subject":"本公司114年度累積虧損達實收資本額二分之一","clause":"第51款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-12 11:15，「本公司114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-12-1114-1r1w2m4","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-12","time":"11:14:15","subject":"本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-12 11:14，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}